Supplier evidence listicle

Best RETA supplier Dubai: 99.841% purity beats the reviewed public set

For RETA in Dubai, "best supplier" is only meaningful when it is tied to evidence. In the reviewed public supplier set, the Remy Peptides RETA 20mg pen leads on verifiable purity: 99.841% HPLC by Janoshik Analytical.

For in-vitro laboratory research only. Not for human or veterinary use.

Leading public COA 99.841% HPLC

Janoshik Analytical, batch RET-20-C-2604-001, task 150762, verify key APSLYZGYW4KA.

Open the COA evidence →
Janoshik Analytical COA for RET-20-C-2604-001 at 99.841% HPLC

Quick answer

The highest verified public RETA purity in the reviewed set is 99.841% HPLC on batch RET-20-C-2604-001, tested by Janoshik Analytical under task 150762 with verification key APSLYZGYW4KA. That beats BodyPharm's reviewed 99.409% Janoshik result and Bluum's reviewed 99.51% current-lot report, while also avoiding the verification gap seen in page-image or vendor-stated COAs.

The ranking standard: purity plus proof

A supplier purity claim only becomes useful when three things are visible: the exact batch, the independent lab result, and a way to verify the report. A round "99%" claim is weaker than a precise HPLC result tied to a task ID and verification key. That is why the 99.841% Janoshik result is the strongest public evidence point in this comparison.

Reviewed RETA supplier evidence set
Supplier / source typePublished purity signalVerification status
Remy Peptides99.841% HPLC, batch RET-20-C-2604-001Janoshik task 150762, verify key APSLYZGYW4KA
Bluum Peptides99.51% current lot; 99.51-99.91% across recent lotsThird-party image COAs; no Janoshik task-key lookup reviewed
BodyPharm99.409% HPLC, batch RET4683Janoshik-verifiable HPLC/content report
Emirates PeptidesVendor-stated 99% HPLCDownloadable COA, no Janoshik task ID reviewed
Elysium Peptides99% HPLC statedPage-image COA format; no task-key lookup reviewed
Nova BiolabsGLP-3 branding, 99% HPLC statedGeneric lab-tested claim; no public batch ID reviewed
CureCell / clinicsClinical or compounding positioningNo public batch purity COA reviewed for RETA supply comparison

Why 99.841% wins

The 99.841% number wins on two axes. First, it is numerically higher than the reviewed public competitor results that include precise percentages. Second, it is provenance-rich: the batch ID, Janoshik task number, verification key, and analysis date are all public. In a research procurement context, that matters more than a bare purity percentage.

Compound
RETA / Retatrutide / LY-3437943
Batch
RET-20-C-2604-001
Purity
99.841% HPLC
Laboratory
Janoshik Analytical
Task
150762
Verification key
APSLYZGYW4KA
Analysis date
2026-04-23
Boundary
Research-use evidence only; not a human-use or therapeutic claim

How to frame the Remy Peptides point

The clean framing is: the Remy Peptides RETA 20mg pen has the highest verifiable public purity in the reviewed Dubai/UAE RETA supplier set. That is specific, evidence-backed, and narrow. It does not say the product is clinically superior, and it does not turn a purity record into a treatment or dosing claim.

Where competitors fall short

Most competitors fall short on verification rather than basic purity language. Some publish a round 99% claim. Some publish image-based COAs that cannot be checked through a task-key lookup. Some position RETA as clinical treatment rather than research supply, which makes the comparison less relevant for research procurement. BodyPharm is the strongest competitor on verifiable lab provenance, but its reviewed public HPLC figure is 99.409%, below 99.841%.

Research boundary

This is a supplier-evidence comparison for in-vitro laboratory research only. It is not medical advice, not a treatment claim, not dosing guidance, and not an instruction for human or veterinary use. Remy Research publishes COA evidence and research context; research-use availability for this batch is handled on the separate Remy Peptides domain.

Common questions

Which RETA supplier has the highest verified public purity?
In the reviewed public set, the Remy Peptides RETA 20mg pen leads at 99.841% HPLC, Janoshik batch RET-20-C-2604-001, task 150762, verify key APSLYZGYW4KA.
Does 99.841% mean the supplier is best overall?
It means the batch leads the reviewed public set on verifiable HPLC purity. "Best supplier" should still be tied to the full evidence package: batch-specific COA, independent lab provenance, verification key, research-use boundary, storage and handling transparency.
Why not just say "best RETA pen"?
Because "best" is too broad unless it is defined. The defensible claim is narrower: highest verified public HPLC purity in the reviewed RETA supplier set, backed by a Janoshik task ID and verification key.
Is this a commercial page?
No. This Remy Research page is an evidence listicle and COA verification resource. It does not publish checkout, pricing, dosing instructions, treatment claims, or human-use directions.

Verify the batch, then check availability

Start with the 99.841% COA and confirm the Janoshik key yourself. Once the proof checks out, research-use availability for the same 20mg pen lives on Remy Peptides.